Apimeds Pharmaceuticals US, Inc (APUS) — Stock Valuation & Research

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

APUS key statistics

Price$1.77
Market cap$2.67M
SectorHealthcare
IndustryBiotechnology
ExchangeAMEX
52-week range1.51-59.7
Beta0.15

Explore APUS's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.